(DES) WisdomTree U.S. SmallCap - Ratings and Ratios
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US97717W6049 • Small Value
DES: Small Cap, Dividend, Stocks, Index, ETF
The WisdomTree U.S. SmallCap Dividend Fund (NYSE ARCA:DES) is designed to track the performance of small-capitalization dividend-paying companies in the U.S. Under normal market conditions, the fund invests at least 95% of its total assets in securities that replicate the economic characteristics of its underlying index. This includes holding constituent securities of the index and other investments with similar economic traits. The funds underlying index is fundamentally weighted, focusing on small-cap firms that generate dividends, providing exposure to both income and growth potential in the small-cap segment.
As a non-diversified fund, it may concentrate its holdings in a smaller number of securities compared to diversified funds. This approach allows for targeted exposure to small-cap dividend payers, which are often characterized by stable cash flows and established business models. The funds methodology emphasizes dividend-paying companies, which historically have demonstrated lower volatility and resilience during market downturns compared to non-dividend payers.
Based on the provided data, here is a 3-month forecast:
From a technical perspective, the fund is currently trading below its 20-day and 50-day moving averages, with the 20-day SMA at 29.63 and the 50-day SMA at 31.40. The 200-day SMA of 33.38 indicates a bearish trend in the medium term. The ATR of 0.92 suggests moderate volatility. If the fund fails to reclaim its 50-day SMA, it may face further downside pressure, potentially testing the 28.50-29.00 range. Conversely, a breakout above the 50-day SMA could signal a reversal, with resistance at 32.00-33.00.
From a fundamental perspective, the funds AUM of $1.7 billion reflects its liquidity and investor confidence. Small-cap dividend payers are likely to remain attractive in a low-yield environment, supported by their ability to generate consistent income. However, broader market conditions, including interest rate changes and economic growth trends, will play a significant role in shaping the funds performance over the next quarter.
Additional Sources for DES ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
DES ETF Overview
Market Cap in USD | 1,717m |
Category | Small Value |
TER | 0.38% |
IPO / Inception | 2006-06-16 |
DES ETF Ratings
Growth Rating | 56.6 |
Fundamental | - |
Dividend Rating | 54.8 |
Rel. Strength | -11 |
Analysts | - |
Fair Price Momentum | 27.26 USD |
Fair Price DCF | - |
DES Dividends
Dividend Yield 12m | 2.81% |
Yield on Cost 5y | 5.28% |
Annual Growth 5y | 5.73% |
Payout Consistency | 94.8% |
DES Growth Ratios
Growth Correlation 3m | -90.8% |
Growth Correlation 12m | 24.2% |
Growth Correlation 5y | 71.8% |
CAGR 5y | 12.32% |
CAGR/Max DD 5y | 0.49 |
Sharpe Ratio 12m | -0.35 |
Alpha | -10.88 |
Beta | 0.829 |
Volatility | 18.03% |
Current Volume | 146.5k |
Average Volume 20d | 175.3k |
As of May 02, 2025, the stock is trading at USD 30.19 with a total of 146,545 shares traded.
Over the past week, the price has changed by -0.02%, over one month by -5.51%, over three months by -10.90% and over the past year by +0.65%.
Partly, yes. Based on ValueRay Analyses, WisdomTree U.S. SmallCap (NYSE ARCA:DES) is currently (May 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 56.55 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of DES as of May 2025 is 27.26. This means that DES is currently overvalued and has a potential downside of -9.71%.
WisdomTree U.S. SmallCap has no consensus analysts rating.
According to ValueRays Forecast Model, DES WisdomTree U.S. SmallCap will be worth about 31.2 in May 2026. The stock is currently trading at 30.19. This means that the stock has a potential upside of +3.31%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 31.2 | 3.3% |